series-b
Stage
About
AusperBio is a clinical-stage biopharmaceutical company focused on developing innovative antisense oligonucleotide (ASO) therapeutics, primarily targeting hepatitis B virus (HBV) and other diseases including viral infections, metabolic, genetic, and immune disorders.
Explore 浩博医药AusperBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.